ChronoScale Holdings Corporatio (CHRN) Stock Price & How to Invest

ChronoScale Corporation is a "neocloud," meaning it buys large clusters of NVIDIA GPUs, installs them in data centers, and rents that accelerated compute to companies running artificial intelligence workloads such as model training, inference, and high-performance computing. It began life as the cloud unit of Applied Digital, a data-center developer, and became a separate public company on May 5, 2026, when that cloud business was combined with the former shell of Ekso Bionics Holdings, which then renamed itself ChronoScale and kept the ticker CHRN on the Nasdaq Capital Market. The company is based in Dallas, Texas. In fiscal 2025 (the year ended May 2025) the cloud unit ran about 6,144 GPUs and generated roughly $84 million of revenue, up about 191% year over year, while posting a net loss of about $73 million as it invested to scale.

The capital structure is unusual and central to the story. Applied Digital exchanged its cloud business for roughly 138 million ChronoScale shares and still owns about 97% of the company, leaving only a small public float. ChronoScale also pays Applied Digital an ongoing quarterly fee equal to about 1% of its consolidated gross revenue plus other service fees, a related-party arrangement to keep in mind. The stated reason for the split was that the cloud business competes with the same hyperscalers and AI companies Applied Digital wants as data-center leasing customers, so separating the two lets each raise capital and pursue customers independently. Because ChronoScale is newly public, tiny relative to its rivals, and reliant on a very short customer list, its shares have been highly volatile since listing.

The risks are substantial and stack together. ChronoScale is deeply unprofitable, reporting a net loss of roughly $73 million on about $84 million of revenue in fiscal 2025, and building GPU capacity is extremely capital intensive, so it may need repeated financing. Customer concentration is severe: filings pointed to a very small number of cloud customers, so losing even one would badly hurt revenue. Applied Digital owns about 97% of the stock and collects a fee on gross revenue, leaving public holders with little control and a thin float that can swing sharply. GPUs depreciate fast and can be made obsolete by newer chips, while competition comes from far larger, better-funded rivals and from the hyperscalers themselves. As a newly public company created through a reverse merger with a former shell, it also carries limited standalone operating history and elevated volatility.

We give no verdict on ChronoScale Holdings Corporatio. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Riding AI compute demand. ChronoScale sells the raw GPU capacity that AI model builders need, a market that has grown quickly as training and inference workloads expand.

The case against. The risks are substantial and stack together.

Read the full bull and bear case on CHRN, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see ChronoScale Holdings Corporatio's investor relations page or your broker.

• Revenue (fiscal 2025, ended May 2025): ~$84 million, up roughly 191% year over year
• Net income (fiscal 2025): ~-$73 million (net loss)
• GPUs deployed (fiscal 2025): ~6,144 GPUs
• Applied Digital ownership: ~97% of shares outstanding
• P/E ratio: not applicable (company is unprofitable)
• Market cap: ~$2.5 billion (stock ~$18 per share, 52-week range roughly $3 to $28)

Figures are approximate and tied to the asOf date; verify live numbers before acting. ChronoScale has no meaningful earnings multiple because it loses money, so the market is valuing it on future AI compute growth rather than current profit. The stock has been very volatile since its May 2026 listing, and the roughly 97% parent ownership means the small public float can amplify price swings in either direction.

Other names that sit close to CHRN: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CHRN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CHRN sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CHRN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

ChronoScale is an early-stage GPU cloud provider with about $84 million in fiscal 2025 revenue, a net loss of roughly $73 million, extreme customer concentration, and a controlling parent that owns about 97% of the stock, so it trades far more on AI-infrastructure sentiment than on current fundamentals.

Whether CHRN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CHRN a buy or a sell?, and where the stock could go from here in the CHRN stock forecast.

For income investors, whether CHRN pays a dividend and how the payout looks is covered in does CHRN pay a dividend? And to weigh CHRN against a peer, read the full side-by-side comparisons: CHRN vs CRWV and CHRN vs NBIS.